|
1
|
Vereide DT, Seto E, Chiu YF, Hayes M,
Tagawa T, Grundhoff A, Hammerschmidt W and Sugden B: Epstein-Barr
virus maintains lymphomas via its miRNAs. Oncogene. 33:1258–1264.
2014. View Article : Google Scholar
|
|
2
|
Bornkamm GW: Epstein-Barr virus and the
pathogenesis of Burkitt’s lymphoma: more questions than answers.
Int J Cancer. 124:1745–1755. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Molyneux EM, Rochford R, Griffin B, Newton
R, Jackson G, Menon G, Harrison CJ, Israels T and Bailey S:
Burkitt’s lymphoma. Lancet. 379:1234–1244. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Drexler HG and Minowada J: History and
classification of human leukemia-lymphoma cell lines. Leuk
Lymphoma. 31:305–316. 1998.PubMed/NCBI
|
|
5
|
Bieging KT, Amick AC and Longnecker R:
Epstein-Barr virus LMP2A bypasses p53 inactivation in a MYC model
of lymphomagenesis. Proc Natl Acad Sci USA. 106:17945–17950. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lassoued S, Ben Ameur R, Ayadi W, Gargouri
B, Ben Mansour R and Attia H: Epstein-Barr virus induces an
oxidative stress during the early stages of infection in B
lymphocytes, epithelial, and lymphoblastoid cell lines. Mol Cell
Biochem. 313:179–186. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cerimele F, Battle T, Lynch R, Frank DA,
Murad E, Cohen C, Macaron N, Sixbey J, Smith K, Watnick RS,
Eliopoulos A, Shehata B and Arbiser JL: Reactive oxygen signaling
and MAPK activation distinguish Epstein-Barr Virus (EBV)-positive
versus EBV-negative Burkitt’s lymphoma. Proc Natl Acad Sci USA.
102:175–179. 2005. View Article : Google Scholar
|
|
8
|
Zheng H, Li LL, Hu DS, Deng XY and Cao Y:
Role of Epstein-Barr virus encoded latent membrane protein 1 in the
carcinogenesis of nasopharyngeal carcinoma. Cell Mol Immunol.
4:185–196. 2007.PubMed/NCBI
|
|
9
|
Ha YJ and Lee JR: Role of TNF
receptor-associated factor 3 in the CD40 signaling by production of
reactive oxygen species through association with
p40phox, a cytosolic subunit of nicotinamide adenine
dinucleotide phosphate oxidase. J Immunol. 172:231–239. 2004.
View Article : Google Scholar
|
|
10
|
Lambeth JD, Kawahara T and Diebold B:
Regulation of Nox and Duox enzymatic activity and expression. Free
Radic Biol Med. 43:319–331. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Devi GS, Prasad MH, Saraswathi I, Raghu D,
Rao DN and Reddy PP: Free radicals antioxidant enzymes and lipid
peroxidation in different types of leukemias. Clin Chim Acta.
293:53–62. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Park SY, Chang I, Kim JY, Kang SW, Park
SH, Singh K and Lee MS: Resistance of mitochondrial DNA-depleted
cells against cell death: role of mitochondrial superoxide
dismutase. J Biol Chem. 279:7512–7520. 2004. View Article : Google Scholar
|
|
13
|
Behrend L, Henderson G and Zwacka RM:
Reactive oxygen species in oncogenic transformation. Biochem Soc
Trans. 31:1441–1444. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Roth D, Krammer PH and Gulow K: Dynamin
related protein 1-dependent mitochondrial fission regulates
oxidative signalling in T cells. FEBS Lett. 588:1749–1754. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Trachootham D, Zhou Y, Zhang H, Demizu Y,
Chen Z, Pelicano H, Chiao PJ, Achanta G, Arlinghaus RB, Liu J and
Huang P: Selective killing of oncogenically transformed cells
through a ROS-mediated mechanism by β-phenylethyl isothiocyanate.
Cancer Cell. 10:241–252. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lin B, Chen Z, Xu Y, Zhang H, Liu J and
Qian X: 7-b, a novel amonafide analogue, cause growth inhibition
and apoptosis in Raji cells via a ROS-mediated mitochondrial
pathway. Leuk Res. 35:646–656. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fengling M, Fenju L, Wanxin W, Lijia Z,
Jiandong T, Zu W, Xin Y and Qingxiang G: Rituximab sensitizes a
Burkitt lymphoma cell line to cell killing by X-irradiation. Radiat
Environ Biophys. 48:371–378. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kuang Y, Balakrishnan K, Gandhi V and Peng
X: Hydrogen peroxide inducible DNA cross-linking agents: targeted
anti-cancer prodrugs. J Am Chem Soc. 133:19278–19281. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fang J, Nakamura H and Iyer AK:
Tumor-targeted induction of oxystress for cancer therapy. J Drug
Target. 15:475–486. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hu ZY, Wang J, Cheng G, Zhu XF, Huang P,
Yang D and Zeng YX: Apogossypolone targets mitochondria and light
enhances its anticancer activity by stimulating generation of
singlet oxygen and reactive oxygen species. Chin J Cancer.
30:41–53. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Acharya A, Das I, Chandhok D and Saha T:
Redox regulation in cancer: a double-edged sword with therapeutic
potential. Oxid Med Cell Longev. 3:23–34. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lee KW and Lee HJ: The roles of
polyphenols in cancer chemoprevention. Biofactors. 26:105–121.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Roy P, George J, Srivastava S, Tyagi S and
Shukla Y: Inhibitory effects of tea polyphenols by targeting
cyclooxygenase-2 through regulation of nuclear factor kappa B, Akt
and p53 in rat mammary tumors. Invest New Drugs. 29:225–231. 2011.
View Article : Google Scholar
|
|
24
|
Talero E, Ávila-Roman J and Motilva V:
Chemoprevention with phytonutrients and microalgae products in
chronic inflammation and colon cancer. Curr Pharm Des.
18:3939–3965. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yamaura M, Mitsushita J, Furuta S, Kiniwa
Y, Ashida A, Goto Y, Shang WH, Kubodera M, Kato M, Takata M, Saida
T and Kamata T: NADPH oxidase 4 contributes to transformation
phenotype of melanoma cells by regulating G2-M cell
cycle progression. Cancer Res. 69:2647–2654. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bedard K and Krause KH: The NOX family of
ROS-generating NADPH oxidases: physiology and pathophysiology.
Physiol Rev. 87:245–313. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mbulaiteye SM, Anderson WF, Ferlay J,
Bhatia K, Chang C, Rosenberg PS, Devesa SS and Parkin DM:
Pediatric, elderly, and emerging adult-onset peaks in Burkitt’s
lymphoma incidence diagnosed in four continents, excluding Africa.
Am J Hematol. 87:573–578. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gu JM, Lim SO, Oh SJ, Yoon SM, Seong JK
and Jung G: HBx modulates iron regulatory protein 1-mediated iron
metabolism via reactive oxygen species. Virus Res. 133:167–177.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Silic-Benussi M, Cavallari I, Vajente N,
Vidali S, Chieco-Bianchi L, Di Lisa F, Saggioro D, D’Agostino DM
and Ciminale V: Redox regulation of T-cell turnover by the p13
protein of human T-cell leukemia virus type 1: distinct effects in
primary versus transformed cells. Blood. 116:54–62. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hutzinger R, Feederle R, Mrazek J,
Schiefermeier N, Balwierz PJ, Zavolan M, Polacek N, Delecluse HJ
and Hüttenhofer A: Expression and processing of a small nucleolar
RNA from the Epstein-Barr virus genome. PLoS Pathog.
5:e10005472009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lu W, Hu Y, Chen G, Chen Z, Zhang H, Wang
F, Feng L, Pelicano H, Wang H, Keating MJ, Liu J, McKeehan W, Wang
H, Luo Y and Huang P: Novel role of NOX in supporting aerobic
glycolysis in cancer cells with mitochondrial dysfunction and as a
potential target for cancer therapy. PLoS Biol. 10:e10013262012.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Prata C, Maraldi T, Fiorentini D, Zambonin
L, Hakim G and Landi L: Nox-generated ROS modulate glucose uptake
in a leukaemic cell line. Free Radic Res. 42:405–414. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Han CY, Umemoto T, Omer M, Den Hartigh LJ,
Chiba T, LeBoeuf R, Buller CL, Sweet IR, Pennathur S, Abel ED and
Chait A: NADPH oxidase-derived reactive oxygen species increases
expression of monocyte chemotactic factor genes in cultured
adipocytes. J Biol Chem. 287:10379–10393. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Block K and Gorin Y: Aiding and abetting
roles of NOX oxidases in cellular transformation. Nat Rev Cancer.
12:627–637. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mochizuki T, Furuta S, Mitsushita J, Shang
WH, Ito M, Yokoo Y, Yamaura M, Ishizone S, Nakayama J, Konagai A,
Hirose K, Kiyosawa K and Kamata T: Inhibition of NADPH oxidase 4
activates apoptosis via the AKT/apoptosis signal-regulating kinase
1 pathway in pancreatic cancer PANC-1 cells. Oncogene.
25:3699–3707. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Singh MM, Irwin ME, Gao Y, Ban K, Shi P,
Arlinghaus RB, Amin HM and Chandra J: Inhibition of the NADPH
oxidase regulates heme oxygenase 1 expression in chronic myeloid
leukemia. Cancer. 118:3433–3445. 2012. View Article : Google Scholar :
|
|
37
|
Ding Y, Chen ZJ, Liu S, Che D, Vetter M
and Chang CH: Inhibition of Nox-4 activity by plumbagin, a
plant-derived bioactive naphthoquinone. J Pharm Pharmacol.
57:111–116. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gianni D, Taulet N, Zhang H, Der
Mardirossian C, Kister J, Martinez L, Roush WR, Brown SJ, Bokoch GM
and Rosen H: A novel and specific NADPH oxidase-1 (Nox1)
small-molecule inhibitor blocks the formation of functional
invadopodia in human colon cancer cells. ACS Chem Biol. 5:981–993.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jaquet V, Marcoux J, Forest E, Leidal KG,
McCormick S, Westermaier Y, Perozzo R, Plastre O, Fioraso-Cartier
L, Diebold B, Scapozza L, Nauseef WM, Fieschi F, Krause KH and
Bedard K: NADPH oxidase (NOX) isoforms are inhibited by celastrol
with a dual mode of action. Br J Pharmacol. 164:507–520. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Verbon EH, Post JA and Boonstra J: The
influence of reactive oxygen species on cell cycle progression in
mammalian cells. Gene. 511:1–6. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Pelicano H, Feng L, Zhou Y, Carew JS,
Hileman EO, Plunkett W, Keating MJ and Huang P: Inhibition of
mitochondrial respiration: a novel strategy to enhance drug-induced
apoptosis in human leukemia cells by a reactive oxygen
species-mediated mechanism. J Biol Chem. 278:37832–37839. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Guo C, Pan ZG, Li DJ, Yun JP, Zheng MZ, Hu
ZY, Cheng LZ and Zeng YX: The expression of p63 is associated with
the differential stage in nasopharyngeal carcinoma and EBV
infection. J Transl Med. 4:232006. View Article : Google Scholar : PubMed/NCBI
|
